The state government has formed two committees under the chief secretary and the cane commissioner on the matter.
Sun maintained it would retain the best of both organisations to build a global pharma company.
A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.
US country head, key departmental heads leave; more likely to follow.
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
No Ebola case detected in the country so far; experts say a robust preparedness plan to fight the virus missing.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
PMO being sent daily updates on food cost situation in four major metropolitan cities to ensure no unusual flare-up.
Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
The move is aimed at reflecting the diversity of India and highlighting the contribution of prominent personalities.
Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
Ministers in the Narendra Modi government have been busy making presentations on their 100 days of work. But what these presentations do not mention is that decisions by ministers have been few, with plenty of papers and files moving to the Prime Minister's Office, which is increasingly emerging as a centralised clearance point, even for routine and ordinary issues. Though policy paralysis was a term used freely for the United Progressive Alliance regime, questions are now being raised about pending decisions across ministries and whether at least some ministers have turned redundant.
New Delhi bureaucrats, accustomed to leisurely lunches, golf in the afternoon and long weekends, have been shaken out of their somnolence, say authors. Fear and suspicion hang heavy over the red-sands.
Experts say it will make GDP growth target of 5.7-5.8% difficult to achieve, while ministries feel late resurgence will help in sowing of rabi crops.
Officials said as part of the reorganisation in the Commission, a move is afoot to strengthen the PEO with new roles, powers and jurisdiction.
The idea is to keep a close watch on real-time price movements, the maximum retail price of medicines and their availability.
The Ministry of Science and Technology has approached about a dozen well-known scientists from across the world in an effort to bring them back to various departments under the ministry, said Jitendra Singh, minister of state (independent charge) for science and technology.
New body to replace Plan panel might retain 40% of existing staff
Ministerial consultations on, with recognition of the potential, and the need to not classify it under the same rules as for pharmaceuticals.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances